Detalhe da pesquisa
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994647
2.
Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules.
Biochem Biophys Res Commun
; 709: 149855, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579618
3.
Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection.
J Viral Hepat
; 31(3): 137-142, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146596
4.
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Hepatology
; 78(5): 1558-1568, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184202
5.
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Liver Int
; 44(1): 113-124, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789669
6.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517286
7.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661715
8.
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Hepatol Res
; 54(4): 382-391, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983642
9.
mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response.
J Gastroenterol Hepatol
; 2024 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403468
10.
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
J Gastroenterol Hepatol
; 39(5): 949-954, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291715
11.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480009
12.
Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach.
Surg Endosc
; 38(2): 757-768, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052887
13.
Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease.
Nutr Metab Cardiovasc Dis
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664121
14.
Outcomes of patients with cerebral microbleeds undergoing percutaneous coronary intervention and dual antiplatelet therapy.
Heart Vessels
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607378
15.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Stroke
; 54(3): 697-705, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734235
16.
Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals.
J Hepatol
; 2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716372
17.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol
; 21(2): 370-379, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051649
18.
A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis.
Am J Gastroenterol
; 118(5): 840-847, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305695
19.
Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
Radiology
; 309(1): e230341, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787670
20.
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.
Invest New Drugs
; 41(3): 512-521, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171720